➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Mallinckrodt
AstraZeneca
Boehringer Ingelheim
Baxter
McKinsey

Last Updated: August 11, 2020

DrugPatentWatch Database Preview

Ceftazidime - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for ceftazidime and what is the scope of freedom to operate?

Ceftazidime is the generic ingredient in ten branded drugs marketed by Acs Dobfar, Aurobindo Pharma Ltd, Wockhardt, B Braun, Glaxosmithkline, Teligent, Hospira, Lilly, and Baxter Hlthcare, and is included in sixteen NDAs. Additional information is available in the individual branded drug profile pages.

There are seventeen drug master file entries for ceftazidime. Five suppliers are listed for this compound.

Recent Clinical Trials for ceftazidime

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
AllerganPhase 2
PfizerPhase 2
PfizerPhase 1

See all ceftazidime clinical trials

Pharmacology for ceftazidime
Medical Subject Heading (MeSH) Categories for ceftazidime

US Patents and Regulatory Information for ceftazidime

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline CEPTAZ ceftazidime INJECTABLE;INJECTION 050646-003 Sep 27, 1990 DISCN No No   Start Trial   Start Trial   Start Trial
Wockhardt CEFTAZIDIME ceftazidime INJECTABLE;INJECTION 065196-001 Oct 15, 2008 AP RX No No   Start Trial   Start Trial   Start Trial
Hospira TAZICEF ceftazidime INJECTABLE;INJECTION 064032-002 Oct 31, 1993 AP RX No No   Start Trial   Start Trial   Start Trial
Teligent FORTAZ IN PLASTIC CONTAINER ceftazidime sodium INJECTABLE;INJECTION 050634-001 Apr 28, 1989 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Merck
Colorcon
Medtronic
Moodys
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.